Publikationen in Zusammenarbeit mit Forschern von Hospital Ramón y Cajal (23)

2024

  1. Emotional intelligence and neurocognition profiles in first-episode psychosis: A two-year follow-up study

    European Neuropsychopharmacology, Vol. 85, pp. 66-77

  2. Inflammatory blood cells and ratios at remission for psychosis relapse prediction: A three-year follow-up of a cohort of first episodes of schizophrenia

    Schizophrenia Research, Vol. 267, pp. 24-31

2023

  1. Relapse, cognitive reserve, and their relationship with cognition in first episode schizophrenia: a 3-year follow-up study

    European Neuropsychopharmacology, Vol. 67, pp. 53-65

  2. The polygenic basis of relapse after a first episode of schizophrenia

    European Neuropsychopharmacology, Vol. 75, pp. 80-92

2022

  1. Oligoclonal IgM bands are a promising biomarker for long-term cognitive outcomes in multiple sclerosis

    Multiple Sclerosis and Related Disorders

  2. Pilot study of an online intervention for young people with a first psychotic episode: Thinkapp

    European Psychiatry, Vol. 65, Núm. S1: Abstracts of the 30th European Congress of Psychiatry, pp. S321-S321

  3. The network structure of cognitive deficits in first episode psychosis patients

    Schizophrenia Research, Vol. 244, pp. 46-54

2021

  1. CPEB alteration and aberrant transcriptome-polyadenylation lead to a treatable SLC19A3 deficiency in Huntington’s disease

    Science Translational Medicine, Vol. 13, Núm. 613

  2. How does neighbourhood socio-economic status affect the interrelationships between functioning dimensions in first episode of psychosis? A network analysis approach

    Health and Place, Vol. 69

  3. Impact of previous tobacco use with or without cannabis on first psychotic experiences in patients with first-episode psychosis

    Schizophrenia Research, Vol. 236, pp. 19-28

  4. The interplay between functioning problems and symptoms in first episode of psychosis: An approach from network analysis

    Journal of Psychiatric Research, Vol. 136, pp. 265-273

  5. The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis

    Psychopharmacology, Vol. 238, Núm. 3, pp. 665-676

2020

  1. Birth weight and antipsychotic induced weight gain: A prenatal programming approach in the PEPs study

    Schizophrenia Research, Vol. 218, pp. 292-294

2019

  1. Gene-environment interaction between an endocannabinoid system genetic polymorphism and cannabis use in first episode of psychosis

    European Neuropsychopharmacology, Vol. 29, Núm. 6, pp. 786-794

2018

  1. Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?

    Psychological Medicine, Vol. 48, Núm. 13, pp. 2247-2256

  2. Use of complementary tests in emergencies and their relation with patient safety incidents

    Journal of Healthcare Quality Research, Vol. 33, Núm. 2, pp. 75-81

2017

  1. Do patients with bipolar disorder and subsyndromal symptoms benefit from functional remediation? A 12-month follow-up study

    European Neuropsychopharmacology, Vol. 27, Núm. 4, pp. 350-359

  2. The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study

    Schizophrenia Research, Vol. 189, pp. 84-90

2016

  1. Cognitive reserve in bipolar disorder: Relation to cognition, psychosocial functioning and quality of life

    Acta Psychiatrica Scandinavica, Vol. 133, Núm. 5, pp. 386-398

  2. Effects of functional remediation on neurocognitively impaired bipolar patients: Enhancement of verbal memory

    Psychological Medicine, Vol. 46, Núm. 2, pp. 291-301